Ghosh, Sriparna <br/><br/>
High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.  [electronic resource] 

 -  Human pathology  Dec 2008 
 - 1835-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1532-8392 
<br/><br/><label>Standard No.: </label>10.1016/j.humpath.2008.06.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--metabolism<br/>Carcinoma, Ductal, Breast--metabolism<br/>Carcinoma, Lobular--metabolism<br/>Connecticut--epidemiology<br/>Female<br/>Fluorescent Antibody Technique, Indirect<br/>Humans<br/>Image Processing, Computer-Assisted<br/>Immunoenzyme Techniques<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Neuropilin-1<br/>Receptors, Vascular Endothelial Growth Factor--metabolism<br/>Survival Rate<br/>Tissue Array Analysis<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Vascular Endothelial Growth Factor Receptor-1--metabolism<br/>Vascular Endothelial Growth Factor Receptor-2--metabolism<br/>Young Adult